Preterm birth and stillbirth rates associated with socioeconomic disparities during COVID-19 pandemic: a population-based cross-sectional study.


Journal

BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309

Informations de publication

Date de publication:
02 2023
Historique:
received: 27 09 2022
accepted: 07 02 2023
entrez: 22 2 2023
pubmed: 23 2 2023
medline: 25 2 2023
Statut: ppublish

Résumé

Conflicting evidence exists on the impact of the COVID-19 pandemic restrictions on preterm birth (PTB) and stillbirth rates. We aimed to evaluate changes in PTB and stillbirth rates before and during the pandemic period and assess the potential effect modification of socioeconomic status (SES). Using the linked administrative health databases from Manitoba, Canada, we conducted a cross-sectional study among all pregnant women, comparing 3.5 years pre-pandemic (1 October 2016 to 29 February 2020) to the first year of the pandemic (1 March 2020 to 31 March 2021). We used generalised linear models to assess the quarterly rates of PTB (<37 weeks) and stillbirths. We calculated the predicted trends based on pre-pandemic period data. Finally, we evaluated the PTB and stillbirth rates among lower and higher SES pregnant women (average annual household income) using subgroup analysis and interaction models. We examined 70 931 pregnancies in Manitoba during the study period. The risk of PTB increased by 7.7% (95%CI 1.01 to 1.13) and stillbirths by 33% (95% CI 1.08 to 1.64) during the pandemic period. Following COVID-19 restrictions implemented in March 2020, there were increases in the quarterly rates of both PTB (immediate increase (β While the onset of COVID-19 pandemic restrictions was not associated with significant effects on stillbirth rates, we observed an immediate and rebound effect on PTB rates. The impact of COVID-19 on preterm birth was dependent on SES, with higher influence on families with lower SES. Further studies are needed to detect future trend changes during pandemic waves after 2021 and assess potential underlying mechanisms.

Sections du résumé

BACKGROUND
Conflicting evidence exists on the impact of the COVID-19 pandemic restrictions on preterm birth (PTB) and stillbirth rates. We aimed to evaluate changes in PTB and stillbirth rates before and during the pandemic period and assess the potential effect modification of socioeconomic status (SES).
METHODS
Using the linked administrative health databases from Manitoba, Canada, we conducted a cross-sectional study among all pregnant women, comparing 3.5 years pre-pandemic (1 October 2016 to 29 February 2020) to the first year of the pandemic (1 March 2020 to 31 March 2021). We used generalised linear models to assess the quarterly rates of PTB (<37 weeks) and stillbirths. We calculated the predicted trends based on pre-pandemic period data. Finally, we evaluated the PTB and stillbirth rates among lower and higher SES pregnant women (average annual household income) using subgroup analysis and interaction models.
RESULTS
We examined 70 931 pregnancies in Manitoba during the study period. The risk of PTB increased by 7.7% (95%CI 1.01 to 1.13) and stillbirths by 33% (95% CI 1.08 to 1.64) during the pandemic period. Following COVID-19 restrictions implemented in March 2020, there were increases in the quarterly rates of both PTB (immediate increase (β
CONCLUSION
While the onset of COVID-19 pandemic restrictions was not associated with significant effects on stillbirth rates, we observed an immediate and rebound effect on PTB rates. The impact of COVID-19 on preterm birth was dependent on SES, with higher influence on families with lower SES. Further studies are needed to detect future trend changes during pandemic waves after 2021 and assess potential underlying mechanisms.

Identifiants

pubmed: 36806202
pii: 10.1136/bmjpo-2022-001686
doi: 10.1136/bmjpo-2022-001686
pmc: PMC9943698
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2005 Mar 5-11;365(9462):891-900
pubmed: 15752534
CMAJ. 2021 Aug 3;193(30):E1164-E1172
pubmed: 34344771
J Glob Health. 2020 Jun;10(1):010104
pubmed: 32355555
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
Matern Child Health J. 2018 Oct;22(10):1430-1435
pubmed: 29600473
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1860-1867
pubmed: 33301434
JAMA Netw Open. 2021 May 3;4(5):e2110104
pubmed: 33978727
BMC Med Res Methodol. 2021 Mar 22;21(1):58
pubmed: 33752604
Am J Perinatol. 2022 Feb;39(3):329-336
pubmed: 34775579
BMC Pregnancy Childbirth. 2021 Oct 6;21(1):676
pubmed: 34615505
Acta Obstet Gynecol Scand. 2021 Oct;100(10):1756-1770
pubmed: 34096034
J Obstet Gynaecol Can. 2022 Jun;44(6):664-674
pubmed: 34973435
Semin Fetal Neonatal Med. 2016 Apr;21(2):68-73
pubmed: 26794420
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
Am J Obstet Gynecol. 2021 Jun;224(6):615.e1-615.e12
pubmed: 33347842
Epidemiology. 2009 Sep;20(5):699-706
pubmed: 19535987
Ann Pharmacother. 1998 Nov;32(11):1152-7
pubmed: 9825079
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Int J Equity Health. 2018 Jan 05;17(1):2
pubmed: 29304810
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
BMC Pregnancy Childbirth. 2021 Jun 4;21(1):416
pubmed: 34088285
Lancet Glob Health. 2020 Oct;8(10):e1273-e1281
pubmed: 32791117
BMC Res Notes. 2022 May 10;15(1):162
pubmed: 35538498
Reprod Health. 2021 Jan 18;18(1):10
pubmed: 33461593
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S38-44
pubmed: 24268083
Lancet Public Health. 2020 Nov;5(11):e604-e611
pubmed: 33065022
Am J Epidemiol. 2009 Jun 1;169(11):1319-26
pubmed: 19363098
Aust N Z J Obstet Gynaecol. 2022 Feb;62(1):62-70
pubmed: 34254286
BMJ. 2020 Sep 1;370:m3320
pubmed: 32873575
BMC Pregnancy Childbirth. 2010 Feb 23;10 Suppl 1:S1
pubmed: 20233382
Eur J Public Health. 2019 Dec 1;29(6):1043-1048
pubmed: 31121034
Arch Dis Child Fetal Neonatal Ed. 2021 Jan;106(1):93-95
pubmed: 32788391
Med Care. 1982 Mar;20(3):266-76
pubmed: 7078285
Med Care. 1993 Mar;31(3):201-12
pubmed: 8450678
J Affect Disord. 2021 Jan 15;279:377-379
pubmed: 33099052

Auteurs

Laila Aboulatta (L)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Kaarina Kowalec (K)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Christine Leong (C)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Psychiatry, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Joseph A Delaney (JA)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Jamie Falk (J)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Silvia Alessi-Severini (S)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.

Dan Chateau (D)

College of Health and Medicine, Australian National University, Canberra, Australian Capital Territory, Australia.

Qier Tan (Q)

Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, Manitoba, Canada.

Katherine Kearns (K)

Department of Family Medicine, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Christina Raimondi (C)

Department of Family Medicine, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Christine Vaccaro (C)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Alekhya Lavu (A)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Lara Haidar (L)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Payam Peymani (P)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Sherif Eltonsy (S)

College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada Sherif.Eltonsy@umanitoba.ca.
Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH